{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:18:25Z","timestamp":1791332305029,"version":"4.3.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00115-024-01629-1","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T14:03:43Z","timestamp":1710165823000},"page":"432-439","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Therapieresistente Zwangsst\u00f6rungen","Treatment-resistant obsessive-compulsive disorders"],"prefix":"10.1007","volume":"95","author":[{"given":"Dominique","family":"Endres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Jelinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Voderholzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"issue":"1","key":"1629_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jaac.2011.09.019","volume":"51","author":"AACAP","year":"2012","unstructured":"AACAP (2012) Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J\u00a0Am Acad Child Adolesc Psychiatry 51(1):98\u2013113. https:\/\/doi.org\/10.1016\/j.jaac.2011.09.019","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"1629_CR2","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1176\/appi.ajp.2019.18101180","volume":"176","author":"L Carmi","year":"2019","unstructured":"Carmi\u00a0L, Tendler\u00a0A, Bystritsky\u00a0A et\u00a0al (2019) Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: a\u00a0prospective multicenter randomized double-blind placebo-controlled trial. Am J Psychiatry 176(11):931\u2013938. https:\/\/doi.org\/10.1176\/appi.ajp.2019.18101180","journal-title":"Am J Psychiatry"},{"issue":"3","key":"1629_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1176\/appi.ajp.2019.19060656","volume":"177","author":"D Denys","year":"2020","unstructured":"Denys\u00a0D, Graat\u00a0I, Mocking\u00a0R et\u00a0al (2020) Efficacy of deep brain stimulation of the ventral anterior limb of the internal capsule for refractory obsessive-compulsive disorder: a\u00a0clinical cohort of 70\u00a0patients. Am J Psychiatry 177(3):265\u2013271. https:\/\/doi.org\/10.1176\/appi.ajp.2019.19060656","journal-title":"Am J Psychiatry"},{"issue":"6","key":"1629_CR4","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/01.jcp.0000095342.32154.54","volume":"23","author":"D Denys","year":"2003","unstructured":"Denys\u00a0D, van der Wee\u00a0N, van Megen\u00a0HJ, Westenberg\u00a0HG (2003) A\u00a0double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder. J\u00a0Clin Psychopharmacol 23(6):568\u2013575. https:\/\/doi.org\/10.1097\/01.jcp.0000095342.32154.54","journal-title":"J Clin Psychopharmacol"},{"key":"1629_CR5","unstructured":"DGPPN (2022) AWMF S3-Leitlinie Zwangsst\u00f6rungen. https:\/\/register.awmf.org\/de\/leitlinien\/detail\/038-017. Zugegriffen: 30. Okt. 2023"},{"issue":"3","key":"1629_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000522136","volume":"91","author":"D Endres","year":"2022","unstructured":"Endres\u00a0D, Mertens\u00a0L, Berger\u00a0B et\u00a0al (2022a) Autoimmune obsessive-compulsive disorder with novel anti-basal ganglia antibodies. Psychother Psychosom 91(3):214\u2013216. https:\/\/doi.org\/10.1159\/000522136","journal-title":"Psychother Psychosom"},{"issue":"1","key":"1629_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41398-021-01700-4","volume":"12","author":"D Endres","year":"2022","unstructured":"Endres\u00a0D, Pollak\u00a0TA, Bechter\u00a0K et\u00a0al (2022b) Immunological causes of obsessive-compulsive disorder: is it time for the concept of an \u201cautoimmune OCD\u201d subtype? Transl Psychiatry 12(1):5. https:\/\/doi.org\/10.1038\/s41398-021-01700-4","journal-title":"Transl Psychiatry"},{"issue":"7","key":"1629_CR8","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s00115-022-01331-0","volume":"93","author":"D Endres","year":"2022","unstructured":"Endres\u00a0D, Domschke\u00a0K, Schiele\u00a0MA (2022c) Neurobiology of obsessive-compulsive disorder. Nervenarzt 93(7):670\u2013677. https:\/\/doi.org\/10.1007\/s00115-022-01331-0","journal-title":"Nervenarzt"},{"issue":"6","key":"1629_CR9","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.beth.2022.02.009","volume":"54","author":"KJ Evey","year":"2023","unstructured":"Evey\u00a0KJ, Steinman\u00a0SA (2023) A\u00a0systematic review of the use of acceptance and commitment therapy to treat adult obsessive-compulsive disorder. Behav Ther 54(6):1006\u20131019. https:\/\/doi.org\/10.1016\/j.beth.2022.02.009","journal-title":"Behav Ther"},{"issue":"4","key":"1629_CR10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.4088\/JCP.14m09044","volume":"76","author":"EB Foa","year":"2015","unstructured":"Foa\u00a0EB, Simpson\u00a0HB, Rosenfield\u00a0D et\u00a0al (2015) Six-month outcomes from a\u00a0randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder. J\u00a0Clin Psychiatry 76(4):440\u2013446. https:\/\/doi.org\/10.4088\/JCP.14m09044","journal-title":"J Clin Psychiatry"},{"key":"1629_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-328738","author":"R Gadot","year":"2022","unstructured":"Gadot\u00a0R, Najera\u00a0R, Hirani\u00a0S et\u00a0al (2022) Efficacy of deep brain stimulation for treatment-resistant obsessive-compulsive disorder: systematic review and meta-analysis. J\u00a0Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2021-328738","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1629_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.euroneuro.2023.09.009","volume":"78","author":"T G\u00f6bel","year":"2023","unstructured":"G\u00f6bel\u00a0T, Maier\u00a0A, Schlump\u00a0A et\u00a0al (2023) Obsessive-compulsive symptoms and 15q11.2q13.1 duplication syndrome. Eur Neuropsychopharmacol 78:67\u201369. https:\/\/doi.org\/10.1016\/j.euroneuro.2023.09.009","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"1629_CR13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s004060070017","volume":"250","author":"HJ Grabe","year":"2000","unstructured":"Grabe\u00a0HJ, Meyer\u00a0C, Hapke\u00a0U et\u00a0al (2000) Prevalence, quality of life and psychosocial function in obsessive-compulsive disorder and subclinical obsessive-compulsive disorder in northern Germany. Eur Arch Psychiatry Clin Neurosci 250(5):262\u2013268. https:\/\/doi.org\/10.1007\/s004060070017","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"2","key":"1629_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1891\/JCPSY-D-20-00027","volume":"35","author":"AG Guzick","year":"2021","unstructured":"Guzick\u00a0AG, McCabe\u00a0RE, Storch\u00a0EA (2021) A\u00a0review of motivational interviewing in cognitive behavioral therapy for obsessive-compulsive disorder. J\u00a0Cogn Psychother 35(2):116\u2013132. https:\/\/doi.org\/10.1891\/JCPSY-D-20-00027","journal-title":"J Cogn Psychother"},{"issue":"13","key":"1629_CR15","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/jama.2017.2200","volume":"317","author":"ME Hirschtritt","year":"2017","unstructured":"Hirschtritt\u00a0ME, Bloch\u00a0MH, Mathews\u00a0CA (2017) Obsessive-compulsive disorder: advances in diagnosis and treatment. JAMA 317(13):1358\u20131367. https:\/\/doi.org\/10.1001\/jama.2017.2200","journal-title":"JAMA"},{"issue":"1","key":"1629_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41380-021-01200-3","volume":"27","author":"OD Howes","year":"2022","unstructured":"Howes\u00a0OD, Thase\u00a0ME, Pillinger\u00a0T (2022) Treatment resistance in psychiatry: state of the art and new directions. Mol Psychiatry 27(1):58\u201372. https:\/\/doi.org\/10.1038\/s41380-021-01200-3","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1629_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00115-013-3961-y","volume":"85","author":"F Jacobi","year":"2014","unstructured":"Jacobi\u00a0F, H\u00f6fler\u00a0M, Strehle\u00a0J et\u00a0al (2014) Mental disorders in the general population : study on the health of adults in Germany and the additional module mental health (DEGS1\u2013MH). Nervenarzt 85(1):77\u201387. https:\/\/doi.org\/10.1007\/s00115-013-3961-y","journal-title":"Nervenarzt"},{"issue":"1","key":"1629_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.beth.2021.05.004","volume":"53","author":"L Jelinek","year":"2022","unstructured":"Jelinek\u00a0L, Balzar\u00a0A, Moritz\u00a0S et\u00a0al (2022) Therapists\u2019 thought-action fusion beliefs predict utilization of exposure in obsessive-compulsive disorder. Behav Ther 53(1):23\u201333. https:\/\/doi.org\/10.1016\/j.beth.2021.05.004","journal-title":"Behav Ther"},{"issue":"2","key":"1629_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000295428","volume":"20","author":"AK K\u00fclz","year":"2010","unstructured":"K\u00fclz\u00a0AK, Lumpp\u00a0A, Herbst\u00a0N et\u00a0al (2010) Welche Funktionen erf\u00fcllen Zwangssymptome? \u2013 Ergebnisse einer Analyse im station\u00e4ren Setting. Verhaltenstherapie 20(2):101\u2013108. https:\/\/doi.org\/10.1159\/000295428","journal-title":"Verhaltenstherapie"},{"issue":"3","key":"1629_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/mpr.1438","volume":"23","author":"S Mack","year":"2014","unstructured":"Mack\u00a0S, Jacobi\u00a0F, Gerschler\u00a0A et\u00a0al (2014) Self-reported utilization of mental health services in the adult German population\u2212evidence for unmet needs? Results of the DEGS1-Mental Health Module (DEGS1-MH). Int J Methods Psychiatr Res 23(3):289\u2013303. https:\/\/doi.org\/10.1002\/mpr.1438","journal-title":"Int J Methods Psychiatr Res"},{"issue":"11","key":"1629_CR21","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1017\/s1092852900014024","volume":"13","author":"D Marazziti","year":"2008","unstructured":"Marazziti\u00a0D, Golia\u00a0F, Consoli\u00a0G et\u00a0al (2008) Effectiveness of long-term augmentation with citalopram to clomipramine in treatment-resistant OCD patients. CNS Spectr 13(11):971\u2013976. https:\/\/doi.org\/10.1017\/s1092852900014024","journal-title":"CNS Spectr"},{"issue":"1","key":"1629_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/wps.20299","volume":"15","author":"D Mataix-Cols","year":"2016","unstructured":"Mataix-Cols\u00a0D, Fern\u00e1ndez de la Cruz\u00a0L, Nordsletten\u00a0AE et\u00a0al (2016) Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder. World Psychiatry 15(1):80\u201381. https:\/\/doi.org\/10.1002\/wps.20299","journal-title":"World Psychiatry"},{"key":"1629_CR23","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.9.1409","author":"D Mataix-Cols","year":"1999","unstructured":"Mataix-Cols\u00a0D, Jenike\u00a0MA (1999) Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry. https:\/\/doi.org\/10.1176\/ajp.156.9.1409","journal-title":"Am J Psychiatry"},{"issue":"2","key":"1629_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/16506073.2018.1494750","volume":"48","author":"S Moritz","year":"2019","unstructured":"Moritz\u00a0S, K\u00fclz\u00a0A, Voderholzer\u00a0U et\u00a0al (2019) Phobie \u00e0\u00a0deux and other reasons why clinicians do not apply exposure with response prevention in patients with obsessive-compulsive disorder. Cogn Behav Ther 48(2):162\u2013176. https:\/\/doi.org\/10.1080\/16506073.2018.1494750","journal-title":"Cogn Behav Ther"},{"issue":"1","key":"1629_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4088\/jcp.v67n0103","volume":"67","author":"PT Ninan","year":"2006","unstructured":"Ninan\u00a0PT, Koran\u00a0LM, Kiev\u00a0A et\u00a0al (2006) High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a\u00a0multicenter double-blind trial. J\u00a0Clin Psychiatry 67(1):15\u201322. https:\/\/doi.org\/10.4088\/jcp.v67n0103","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"1629_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1017\/S1461145702002900","volume":"5","author":"S Pallanti","year":"2002","unstructured":"Pallanti\u00a0S, Hollander\u00a0E, Bienstock\u00a0C et\u00a0al (2002) Treatment non-response in OCD: methodological issues and operational definitions. Int J Neuropsychopharmacol 5(2):181\u2013191. https:\/\/doi.org\/10.1017\/S1461145702002900","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"1629_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41398-023-02368-8","volume":"13","author":"K Runge","year":"2023","unstructured":"Runge\u00a0K, Reisert\u00a0M, Feige\u00a0B et\u00a0al (2023) Deep clinical phenotyping of patients with obsessive-compulsive disorder: an approach towards detection of organic causes and first results. Transl Psychiatry 13(1):83. https:\/\/doi.org\/10.1038\/s41398-023-02368-8","journal-title":"Transl Psychiatry"},{"issue":"1","key":"1629_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/mp.2008.94","volume":"15","author":"AM Ruscio","year":"2010","unstructured":"Ruscio\u00a0AM, Stein\u00a0DJ, Chiu\u00a0WT, Kessler\u00a0RC (2010) The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 15(1):53\u201363. https:\/\/doi.org\/10.1038\/mp.2008.94","journal-title":"Mol Psychiatry"},{"issue":"7","key":"1629_CR29","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s00115-022-01332-z","volume":"93","author":"F Schirmbeck","year":"2022","unstructured":"Schirmbeck\u00a0F, Zink\u00a0M (2022) Obsessive-compulsive symptoms in psychotic disorders: pathogenesis and treatment. Nervenarzt 93(7):688\u2013694. https:\/\/doi.org\/10.1007\/s00115-022-01332-z","journal-title":"Nervenarzt"},{"key":"1629_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.drugalcdep.2015.12.034","volume":"160","author":"J Shakeri","year":"2016","unstructured":"Shakeri\u00a0J, Farnia\u00a0V, Karimi\u00a0AR et\u00a0al (2016) The prevalence and clinical features of amphetamine-induced obsessive compulsive disorder. Drug Alcohol Depend 160:157\u2013162. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.12.034","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"1629_CR31","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamapsychiatry.2013.1932","volume":"70","author":"HB Simpson","year":"2013","unstructured":"Simpson\u00a0HB, Foa\u00a0EB, Liebowitz\u00a0MR et\u00a0al (2013) Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a\u00a0randomized clinical trial. JAMA Psychiatry 70(11):1190\u20131199. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.1932","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"1629_CR32","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S2215-0366(16)30069-4","volume":"3","author":"P Skapinakis","year":"2016","unstructured":"Skapinakis\u00a0P, Caldwell\u00a0DM, Hollingworth\u00a0W et\u00a0al (2016) Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a\u00a0systematic review and network meta-analysis. Lancet Psychiatry 3(8):730\u2013739. https:\/\/doi.org\/10.1016\/S2215-0366(16)30069-4","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"1629_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-019-0102-3","volume":"5","author":"DJ Stein","year":"2019","unstructured":"Stein\u00a0DJ, Costa\u00a0DLC, Lochner\u00a0C et\u00a0al (2019) Obsessive-compulsive disorder. Nat Rev Dis Primers 5(1):52. https:\/\/doi.org\/10.1038\/s41572-019-0102-3","journal-title":"Nat Rev Dis Primers"},{"key":"1629_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsc.2023.06.003","author":"ER Steuber","year":"2023","unstructured":"Steuber\u00a0ER, McGuire\u00a0JF (2023) A\u00a0meta-analysis of transcranial magnetic stimulation in obsessive-compulsive disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. https:\/\/doi.org\/10.1016\/j.bpsc.2023.06.003","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"2","key":"1629_CR35","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1176\/ajp.155.2.264","volume":"155","author":"SE Swedo","year":"1998","unstructured":"Swedo\u00a0SE, Leonard\u00a0HL, Garvey\u00a0M et\u00a0al (1998) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50\u00a0cases. Am J Psychiatry 155(2):264\u2013271. https:\/\/doi.org\/10.1176\/ajp.155.2.264","journal-title":"Am J Psychiatry"},{"issue":"7","key":"1629_CR36","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s00115-022-01336-9","volume":"93","author":"U Voderholzer","year":"2022","unstructured":"Voderholzer\u00a0U, Favreau\u00a0M, Rubart\u00a0A et\u00a0al (2022) Treatment of obsessive-compulsive disorders: recommendations of the revised S3 guidelines on obsessive-compulsive disorders. Nervenarzt 93(7):678\u2013687. https:\/\/doi.org\/10.1007\/s00115-022-01336-9","journal-title":"Nervenarzt"},{"issue":"10","key":"1629_CR37","doi-asserted-by":"publisher","first-page":"e14522","DOI":"10.1111\/ijcp.14522","volume":"75","author":"G Wang","year":"2021","unstructured":"Wang\u00a0G, Si\u00a0T, Imperato\u00a0JS et\u00a0al (2021) Impact of sertraline daily treatment regimen on adherence, persistence and healthcare resource utilisation in patients with major depressive disorder or obsessive-compulsive disorder: a\u00a0real-world evidence analysis from the United States. Int J Clin Pract 75(10):e14522. https:\/\/doi.org\/10.1111\/ijcp.14522","journal-title":"Int J Clin Pract"},{"key":"1629_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pnpbp.2018.12.009","volume":"90","author":"DD Zhou","year":"2019","unstructured":"Zhou\u00a0DD, Zhou\u00a0XX, Li\u00a0Y et\u00a0al (2019) Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: A\u00a0network meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 90:277\u2013287. https:\/\/doi.org\/10.1016\/j.pnpbp.2018.12.009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01629-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-024-01629-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01629-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T10:02:39Z","timestamp":1714730559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-024-01629-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1629"],"URL":"https:\/\/doi.org\/10.1007\/s00115-024-01629-1","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,11]]},"assertion":[{"value":"7 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.\u00a0Endres, L.\u00a0Jelinek und U.\u00a0Voderholzer geben an, dass kein Interessenkonflikt besteht. K.\u00a0Domschke: Innerhalb der letzten drei Jahre: Mitglied \u201aSteering Committee Neurosciences\u2018 und Referentenhonorare, Janssen-Cilag.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}